long half-life and large variability [Regulatives / Guidelines]

posted by martin  – Austria, 2020-07-29 14:57 (320 d 13:44 ago) – Posting: # 21798
Views: 2,125

Dear all,

I would appreciate the forum members thoughts on the following situation.

In short:My interpretation of regulatoy guidelines: adding additional fixed effect factors to the factors mentioned in the guidelines is typically considered as not acceptable by regulators.

best regards & looking forward to some ideas to potentially address this situation

martin

Complete thread:

Activity
 Admin contact
21,518 posts in 4,498 threads, 1,524 registered users;
online 8 (0 registered, 8 guests [including 7 identified bots]).
Forum time: Tuesday 04:42 UTC (Europe/Vienna)

I suppose it is tempting, if the only tool you have is a hammer,
to treat everything as if it were a nail.    Abraham Maslow

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5